COMMUNIQUÉS West-GlobeNewswire

IBA – ACQUISITION D’ACTIONS PROPRES
07/04/2026
Louvain-la-Neuve, Belgique, 7 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award
07/04/2026
ANAHEIM, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- American Botanical Council (ABC) presented Natural Remedies with the prestigious 2026 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award during [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
07/04/2026
Déclaration de transactions sur actions propres Paris, France (7 avril 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 1 er avril 2026 au [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/04/2026
Nantes, le 7 avril 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025
07/04/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 07 avril 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
GENFIT Announces Publication of the 2025 Universal Registration Document
07/04/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 07, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
07/04/2026
BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, [...]
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
07/04/2026
~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ WEXFORD, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen [...]
IBA – ACQUISITION OF OWN SHARES
07/04/2026
Louvain-la-Neuve, Belgium, April 7 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
EssilorLuxottica: Disclosure of transactions in own shares
07/04/2026
Disclosure of transactions in own shares Paris, France (April 7, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that from [...]
Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients' Side Effects Risk for GlucoZen
07/04/2026
A 2026 informational overview addressing common consumer research topics including GlucoZen Drops side effects, ingredient dosage transparency, blood sugar supplement safety considerations, refund and return policy [...]
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
07/04/2026
New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base PONTE VEDRA, Fla., April 07, 2026 (GLOBE [...]
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
07/04/2026
TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) and BioXtek Inc. (“ [...]
Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™
07/04/2026
The First Shelf-Stable Lyophilized Amniotic Graft Containing HC-HA/PTX3 Designed for Efficient Workflow for Patients with Mild-to-Moderate Dry Eye ROSWELL, Ga., April 07, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc [...]
Death by a Thousand Vendors: 81% of Employers Are Hiring Just to Keep Up with Digital Health Vendor Sprawl
07/04/2026
Solera Health research reveals the operational & administrative cost of managing digital health vendors is rivaling the savings they were designed to deliver PHOENIX, April 07, 2026 (GLOBE NEWSWIRE) -- More than 40 [...]
PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications
07/04/2026
BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced [...]
Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP
07/04/2026
BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Folia Health today announced a collaboration with argenx to launch a first-of-its-kind, at-home observational real-world evidence initiative supporting individuals living with [...]
Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
07/04/2026
BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Lumin Health, a physician-led provider of interventional behavioral health care offering SPRAVATO® (esketamine) nasal spray and ketamine-based therapies in a purpose-built [...]
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
07/04/2026
RESEARCH TRIANGLE PARK, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics today provided an update on recent communications with the U.S. Food and Drug Administration (FDA) related to its Investigational [...]

Pages